Is Vitamin D Beneficial to Alzheimer Disease? A Surprising Dilemma

CNS Neuroscience and Therapeutics

Volumn 18, Issue 7, 2012, Pages 601-603

  Qiao, De Li ^b   Zhang, She Qing ^a   Giunta, Brian ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Tongji University School of Medicine   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIHISTAMINIC AGENT; CHOLINESTERASE INHIBITOR; COLECALCIFEROL; GAMMA SECRETASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOMODULATION; MICROGLIA; OPTICAL DENSITY; PROTEIN SECRETION; SENILE PLAQUE; VITAMIN D DEFICIENCY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL LINE; HUMANS; MICROGLIA; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84863526941     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00335.x     Document Type: Article

References (10)

1. Rezai-Zadeh K, Shytle D, Sun N, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005;25:8807-8814.
2. Yankner BA, Lu TJ. Amyloid β-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 2009;284:4755-4759.
3. Sachdeva D, Burns A. Dimebolin in dementia. CNS Neurosci Ther 2011;17:199-205.
4. Caraci F, Battaglia G, Bruno V, et al. TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther 2011;17:237-249.
5. Martorana A, Esposito Z, Koch G. Beyond the cholinergic hypothesis: Do current drugs work in Alzheimer's disease? CNS Neurosci Ther 2010;16:235-245.
6. Panza F, Frisardi V, Imbimbo BP, et al. γ-secretase inhibitors for the treatment of Alzheimer's disease: The current state. CNS Neurosci Ther 2010;16:272-284.
7. Giunta B, Fernandez F, Nikolic WV, et al. Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation 2008;5:51.
8. β peptide-induced microglial MAPK activation. PLOS One 2008;3:e2135.
9. 3 and neurocognitive dysfunction: Preventing "D"ecline? Mol Aspects Med 2008;29:415-422.
10. 3. Glia 2000;31:59-68.